GSD82
Well-Known Member
- Joined
- Nov 3, 2020
- Messages
- 3,461
- Likes
- 5,735
I don't think its a given for single injection of the J&J vaccine. They just ran another arm in their studies that compared single injection. Smart on their part.All of three (Moderna, Pfizer and AZ) require 2 doses. I think the J&J one will be the first approved that will only require one dose
https://www.washingtonpost.com/health/2020/11/17/covid-vaccines-what-you-need-to-know/?arc404=true
The literature I reviewed prior to ordering showed an agreement rate with PCR confirmation around 95%. The sample size was a little small for my liking, though.How trustworthy are those do you think
The literature I reviewed prior to ordering showed an agreement rate with PCR confirmation around 95%. The sample size was a little small for my liking, though.
As with all tests, if it is used appropriately (on someone you suspect has a reasonable chance of actually having the illness), it is a more reliable result.
Re the different vaccines, cost, and storage, etc.
Why wouldn't you want all you could get? An extra $2 billion to save 3 months' time or so seems like an easy yes. I am willing to believe that it was based on practical realities, but it sure does seem that there may be something going on here between Trump administration and Pfizer that derailed that. Guess we will find out in time.
No surprise - just shows how the media distorts reality.
U.S. Media Readers 'Strongly Prefer Negative Stories About COVID-19'
The tone of the coverage was only weakly correlated with the reality of the course of the pandemic: There were more than five times as many media articles about rising coronavirus case numbers as there were articles about decreasing coronavirus case numbers, even during the times when cases were actually declining.
The negative coverage was particularly pronounced with respect to two pandemic-related issues: vaccines and schools. On vaccine prospects, U.S. coverage "emphasized caveats from health officials and experts downplaying the optimistic timeline and past success" of vaccine scientists. Indeed, "the terms 'Trump and hydroxychloroquine' receive more coverage than do all stories about companies and researchers developing vaccines," according to the NBER.
Similarly, U.S. media overwhelmingly took a negative view of reopening schools, contrary to both the emerging scientific consensus—which has generally held that it is safe to reopen many schools—and the tone of coverage elsewhere.
We turned them down because we don’t need them. Young, healthy people (adults and children) won’t need a vaccine. Gen Xers like me who have had Covid have about 6 months worth of immunity and won’t need a vaccine immediately. The only people who should get a vaccine once they’re available are at-risk groups, medical workers and other people who work for employers that mandate a vaccine for their employees.Maybe so. Maybe no.
We will find out. And by then Trump will be out of the picture and we can find out why we turned down those 100 million doses.
Maybe so. Maybe no.
We will find out. And by then Trump will be out of the picture and we can find out why we turned down those 100 million doses.
HHS announced up to $1.2 billion in support for AstraZeneca's candidate vaccine, developed in conjunction with the University of Oxford. The agreement is to make available at least 300 million doses of the vaccine for the United States,
HHS announced up to $1.95 billion in funds to Pfizer for the large-scale manufacturing and nationwide distribution of 100 million doses of their vaccine candidate.
Sanofi and GlaxoSmithKline's (GSK) investigational adjuvanted vaccine. By funding the manufacturing effort, the federal government will own the approximately 100 million doses expected to result from the demonstration project.
delivery of Johnson & Johnson's (Janssen) investigational vaccine candidate. Under the terms of the agreement, the U.S. Government will own the resulting 100 million doses of vaccine, and will have the option to acquire more. T
Moderna's investigational vaccine candidate. Under the terms of the agreement, the U.S. Government will own the resulting 100 million doses of vaccine, and will have the option to acquire more.
We turned them down because we don’t need them. Young, healthy people (adults and children) won’t need a vaccine. Gen Xers like me who have had Covid have about 6 months worth of immunity and won’t need a vaccine immediately. The only people who should get a vaccine once they’re available are at-risk groups, medical workers and other people who work for employers that mandate a vaccine for their employees.
Member when the US worrying about vaccinating its citizens first and hoarding doses was wrong?Re the different vaccines, cost, and storage, etc.
Why wouldn't you want all you could get? An extra $2 billion to save 3 months' time or so seems like an easy yes. I am willing to believe that it was based on practical realities, but it sure does seem that there may be something going on here between Trump administration and Pfizer that derailed that. Guess we will find out in time.